Phase-3 drug trial for refractory rheumatoid arthritis succeeds
Thursday, March 31, 2016 - 11:20
in Health & Medicine
A new drug appears to help people who suffer from rheumatoid arthritis, but eventually stop benefitting from the use of the current top treatment: injectable, bioengineered proteins that interfere with the action of a powerful inflammatory substance.